Rates of Cardiovascular Events Were Lower in Type 2 Diabetic Patients with Pioglitazone Treatment After Zotarolimus-Eluting Stent Implantation During the Three-Year Follow-Up

被引：0

作者：

Hong, Soon Jun ^{[1
]}

Kim, Je Sang ^{[1
]}

Park, Jae Hyoung ^{[1
]}

Ahn, Chul-Min ^{[1
]}

Lim, Do-Sun ^{[1
]}

机构：

[1] Korea Univ, Dept Cardiol, Anam Hosp, Seoul, South Korea

来源：

CIRCULATION | 2011年 / 124卷 / 21期

关键词：

Ppar; Cardiovascular disease prevention;

D O I：

暂无

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

A15566

引用

页数：2

共 50 条

[1] Three-Year Cardiovascular Event Rates Were Lower in Type 2 Diabetic Patients with Pioglitazone Treatment after Zotarolimus-Eluting Stent Implantation
Hong, Soon Jun
Kim, Je Sang
Park, Jae Hyoung
Ahn, Chul-Min
Lim, Do-Sun
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2011, 58 (20) : B26 - B26
[2] Three-Year Follow-up of a New Zotarolimus-Eluting Stent: Results of the RESOLUTE First-In-Man Trial
Meredith, Ian T.
Worthley, Stephen G.
Walters, Darren L.
Whitbourn, Robert
AMERICAN JOURNAL OF CARDIOLOGY, 2009, 104 (6A): : 153D - 154D
[3] The Effects of Pioglitazone on Neointima Volume and Atherosclerosis Progression at Eight Months after Zotarolimus-Eluting Stent Implantation in Diabetic Patients
Hong, Soon Jun
Shim, Wan Joo
Park, Seong Mi
Park, Jae Suk
Kim, Yong Hyun
Ahn, Chul Min
Lim, Do-Sun
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2009, 53 (10) : A30 - A30
[4] THE EFFECTS OF PIOGLITAZONE ON NEOINTIMA VOLUME AND ATHEROSCLEROSIS PROGRESSION AT EIGHT MONTHS AFTER ZOTAROLIMUS-ELUTING STENT IMPLANTATION IN DIABETIC PATIENTS
Hong, S. J.
Goh, C. W.
Lee, K-M
Ahn, C. M.
Lim, D. S.
ATHEROSCLEROSIS SUPPLEMENTS, 2009, 10 (02)
[5] Spontaneous resolution of pseudoaneurysm after zotarolimus-eluting stent implantation: imaging evidence at 13 months of follow-up
Ichikawa M.
Kijima Y.
Cardiovascular Intervention and Therapeutics, 2015, 30 (2) : 168 - 170
[6] Comparison of the Major Clinical Outcomes for the Use of Endeavor® and Resolute Integrity® Zotarolimus-Eluting Stents During a Three-Year Follow-up
Kim, Yong Hoon
Her, Ae-Young
Rha, Seung-Woon
Choi, Byoung Geol
Choi, Se Yeon
Byun, Jae Kyeong
Park, Yoonjee
Kang, Dong Oh
Jang, Won Young
Kim, Woohyeun
Choi, Cheol Ung
Park, Chang Gyu
Seo, Hong Seog
GLOBAL HEART, 2020, 15 (01)
[7] Late Safety and Efficacy of a Zotarolimus-Eluting Stent Compared with a Paclitaxel-Eluting Stent in Patients with De Novo Coronary Lesions: Three-Year Follow-up from the ENDEAVOR IV Trial
Leon, Martin B.
Mauri, Laura
O'Shaughnessy, Charles
Ovelie, Paul A.
McLaurin, Brent T.
Solomon, Stuart L.
Ball, Michael
Douglas, John S.
Cutlip, Donald E.
Kandzari, David E.
AMERICAN JOURNAL OF CARDIOLOGY, 2009, 104 (6A): : 150D - 150D
[8] THREE-YEAR CLINICAL RESULTS OF PATIENTS RANDOMIZED TO 3 OR 12 MONTHS OF DUAL ANTIPLATELET AFTER ENDEAVOR ZOTAROLIMUS-ELUTING STENT IMPLANTATION IN OPTIMIZE
Feres, Fausto
Costa, Ricardo
Abizaid, Alexandre
Marin-Neto, Jose
Botelho, Roberto
De Paula, Joao
Mangione, Jose
Meireles, George
Castello, Helio
Nicolela, Eduardo
Perin, Marco
Devito, Fernando
Labrunie, Andre
Salvadori, Decio
Bhatt, Deepak
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2016, 67 (13) : 189 - 189
[9] Four-year clinical follow-up after implantation of the endeavor zotarolimus-eluting stent: ENDEAVOR I, the first-in-human study
Meredith, Ian T.
Ormiston, John
Whitbourn, Robert
Kay, I. Patrick
Muller, David
Popma, Jeffrey J.
Cutlip, Donald E.
Fitzgerald, Peter J.
AMERICAN JOURNAL OF CARDIOLOGY, 2007, 100 (8B): : 56M - 61M
[10] CELLULAR AND MOLECULAR CHANGES ASSOCIATED WITH INHIBITORY EFFECT OF PIOGLITAZONE ON NEOINTIMAL GROWTH IN PATIENTS WITH TYPE 2 DIABETES AFTER ZOTAROLIMUS-ELUTING STENT IMPLANTATION
Ahn, Chul Min
Hong, Soon Jun
Kim, Ju Hwan
Lee, Kyoung-Mi
Kim, Je Sang
Park, Jae Hyoung
Lim, Do-Sun
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2011, 57 (14) : E1914 - E1914

← 1 2 3 4 5 →